# FDA Inspection 1267516 - Syngene International Ltd. - February 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/9e2cd4f2-8444-47b4-858a-df762b70d6f0
Source feed: FDA_Inspections

> FDA Inspection 1267516 for Syngene International Ltd. on February 20, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267516
- Company Name: Syngene International Ltd.
- Inspection Date: 2025-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267516 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/e53f5132-0908-4433-8fe6-873789f19a38)
- [FDA Inspection 1267516 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/230e388a-d397-44bb-aece-f09b1adcdf84)
- [FDA Inspection 1267516 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/18a0c47e-16df-4cd3-be8f-b4d9a123123b)
- [FDA Inspection 1267516 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/10771fea-4732-4a9c-88eb-b573530de7b2)
- [FDA Inspection 1193108 - 2022-11-15](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/9c646ed8-0fa4-4516-8c71-0bee3741cd26)

Company: https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c